New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 4782 | Org 25543 hydrochloride | Potent and selective GlyT2 inhibitor |
| 4615 | MEDICA 16 | FFA1 (GPR40) agonist. Also inhibits ATP citrate lyase |
| 3496 | BX 471 | Potent, selective CCR1 antagonist |
| 3094 | Flavopiridol hydrochloride | Cyclin-dependent kinase inhibitor |
| 4853 | 8-pCPT-2-O-Me-cAMP-AM | Selective Epac activator; cell-permeable analog of 8CPT-2Me-cAMP (Cat. No. 1645) |
| 4629 | GSK2578215A | Potent, selective LRRK2 inhibitor; brain penetrant |
| 4863 | CA 074 | Selective cathepsin B inhibitor |
| 4857 | Amlexanox | Inhibitor of TBK1 and IKKε; antiallergic agent |
| 4852 | Carbetocin | Oxytocin analog |
| 4823 | PF 05212384 | Potent and selective dual PI 3-kinase/mTOR inhibitor |
| 4821 | PF 03814735 | Aurora kinase A and B inhibitor |
| 4820 | PF 04691502 | Dual PI 3-K/mTOR inhibitor |
| 4818 | PF 04418948 | Potent and selective EP2 receptor antagonist |
| 4810 | BAM 7 | Selective Bax activator; induces Bax-mediated apoptosis |
| 4565 | ML 228 | HIF pathway activator |
| 3946 | TNP | Inhibitor of IP6K; also inhibits IP3K |
| 4817 | SKPin C1 | Inhibits Skp2-mediated p27 degradation; induces cell cycle arrest |
| 4757 | Latanoprost | FP prostaglandin receptor agonist; also exhibits agonist activity at EP1 and EP3 receptors |